Results 201 to 210 of about 6,319,108 (303)

Self‐ and Caregiver‐Reported Choice‐Making in Autistic Adults: Development and Validation of the AASPIRE–Choices and Decisions Scale

open access: yesAutism Research, EarlyView.
ABSTRACT Self‐determination has been assessed as an internal psychological construct. External factors may also affect self‐determination, but opportunities to make choices and decisions remain understudied. We developed and evaluated the AASPIRE‐Choices and Decisions Scale (AASPIRE‐CDS), a new measure of autistic adults' opportunities to make choices ...
So Yoon Kim   +14 more
wiley   +1 more source

Correction: BH3-only sensors Bad, Noxa and Puma are Key Regulators of Tacaribe virus-induced Apoptosis. [PDF]

open access: yesPLoS Pathog
Holzerland J   +5 more
europepmc   +1 more source

Cefepime exposure in prolonged or intermittent infusion in critically ill children

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Cefepime is commonly used in critically ill children for whom there is a high between‐subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, prolonged infusion of beta‐lactams seems to be the most efficient.
Marc Hobeika   +12 more
wiley   +1 more source

Population pharmacokinetics of levetiracetam in term neonates with hypoxic–ischemic encephalopathy and therapeutic hypothermia: The LEVNEONAT‐1 study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim This study aimed to describe the pharmacokinetics (PK) of levetiracetam (LEV) in term neonates treated for neonatal seizures secondary to hypoxic–ischemic encephalopathy (HIE). Methods Fifteen neonates were included and received a loading dose ranging from 30 to 60 mg/kg followed by eight maintenance doses corresponding to one‐fourth of the loading
Léo Mimram   +9 more
wiley   +1 more source

Glucagon‐like peptide‐1 receptor agonists in schizophrenia spectrum disorders: A systematic review and meta‐analysis of efficacy, safety and mental health outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims The purpose of this study is to evaluate efficacy, safety and mental‐health outcomes of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in adults with overweight or obesity and antipsychotic‐treated schizophrenia‐spectrum disorders. Methods PubMed/MEDLINE, Embase, PsycINFO, CENTRAL, Virtual Health Library (VHL) (Biblioteca Virtual em Saúde, BVS),
Débora Regina de Aguiar   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy